MASC Trials is governed by a volunteer Board of Directors, comprising representatives of specialist disciplines from leading melanoma and skin cancer institutions across Australia and New Zealand, as well as members from the lay community. Its Scientific Advisory Board is supported by seven Discipline-Specific Advisories to facilitate robust scientific review of new trial proposals and supervision of ongoing research.
This collective leadership group of over 70 specialists and researchers works together to develop and plan new trials, receive updates on trials in process, and discuss new directions in melanoma medicine in order to improve the lives of patients.
